keine Finanzberatung
🔍 Search…
📊 Portfolio ← All

MRK.DE · Merck KGaA

DAX · XETRA

Risiko 4/10 · Diversified Science Platform · €144.25 ▲ 1.76%

Kennzahlen

  • Price €144.25
  • Market cap €62.7B
  • P/E (ttm) 24.74
  • Div yield 1.55%
  • 52-wk range €100.70 – €148.65

Wichtigste Risiken

  • Life-science tools demand normalisation/destocking (Life Science segment EBITDA) — HIGH
  • Semiconductor cycle in Electronics/materials (Electronics revenue) — MED
  • Late-stage pharma pipeline execution (Long-term revenue renewal) — MED
  • EUR appreciation vs. USD/CNY (Reported earnings translation) — LOW

Fazit

Well-diversified and family-controlled; the life-science destocking cycle is the clearest near-term earnings headwind.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.